(Q36954203)

17 August 2017

1 reference

title

Function of COX-2 and prostaglandins in neurological disease (English)

1 reference

17 August 2017

Liang X

1

1 reference

17 August 2017

Wu L

2

1 reference

17 August 2017

Wang Q

3

1 reference

17 August 2017

Hand T

4

1 reference

17 August 2017

Bilak M

5

1 reference

17 August 2017

McCullough L

6

1 reference

17 August 2017

Andreasson K

7

1 reference

17 August 2017

publication date

1 September 2007

1 reference

Journal of Molecular Neuroscience

17 August 2017

published in

1 reference

17 August 2017

volume

33

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

94-99

1 reference

Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene

17 August 2017

cites work

1 reference

12 December 2020

Cyclooxygenases and the central nervous system

1 reference

12 December 2020

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

1 reference

12 December 2020

Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

1 reference

12 December 2020

Divergent effects of prostaglandin receptor signaling on neuronal survival

1 reference

12 December 2020

Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family

1 reference

12 December 2020

Characterization of inducible cyclooxygenase in rat brain

1 reference

12 December 2020

Prostaglandin and thromboxane biosynthesis

1 reference

12 December 2020

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity

1 reference

12 December 2020

Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation

1 reference

12 December 2020

Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids

1 reference

12 December 2020

Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia

1 reference

12 December 2020

Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia

1 reference

12 December 2020

Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells

1 reference

12 December 2020

Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction.

1 reference

12 December 2020

Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor

1 reference

12 December 2020

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

12 December 2020

PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra.

1 reference

12 December 2020

Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice.

1 reference

12 December 2020

Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage

1 reference

12 December 2020

Prostaglandin D2 mediates neuronal protection via the DP1 receptor

1 reference

12 December 2020

Protection by prostaglandins from glutamate toxicity in cortical neurons

1 reference

12 December 2020

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

1 reference

12 December 2020

Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity

1 reference

12 December 2020

Prostaglandin E2 protects cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity

1 reference

12 December 2020

Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II

1 reference

12 December 2020

Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.

1 reference

12 December 2020

Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid

1 reference

12 December 2020

Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS.

1 reference

12 December 2020

Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

1 reference

12 December 2020

The Cycloxygenase-2 inhibitor SC58236 is neuroprotective in an in vivo model of focal ischemia in the rat.

1 reference

12 December 2020

Prostaglandins act as neurotoxin for differentiated neuroblastoma cells in culture and increase levels of ubiquitin and beta-amyloid

1 reference

12 December 2020

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration

1 reference

12 December 2020

Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent

1 reference

12 December 2020

A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis

1 reference

12 December 2020

Prostanoid receptors: subtypes and signaling

1 reference

12 December 2020

A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group

1 reference

12 December 2020

Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor

1 reference

12 December 2020

Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2

1 reference

12 December 2020

COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex

1 reference

12 December 2020

10.1007/S12031-007-0058-8

Identifiers

DOI

1 reference

17 August 2017

1 reference